Method for treatment of dysmenorrhea
View Patent ↗A method of treatment of dysmenorrhea in the context of oral contraception characterized by daily administration of ethinylestradiol and drospirenone in an extended regimen.
1. A method for reducing dysmenorrhea by administering 20 μg ethinylestradiol and drospirenone in a daily extended regimen uninterruptedly for 42-126 days .
2. A method according to claim 1 wherein the daily amount of drospirenone is in the range of 2 mg to 4 mg.
3. A method according to claim 2 wherein the daily amount of drospirenone is 3 mg.
4. A method according to claim 1 wherein ethinylestradiol and drospirenone are administered daily and uninterruptedly for 84 days followed by 7 days of non administration.
5. A method according to claim 1 wherein the uninterrupted administration of ethinylestradiol and drospirenone is for more than 110 days.
6. A method for reducing dysmenorrhea by administering 20 μg of ethinylestradiol and 2 mg to 4 mg of drospirenone, daily and uninterruptedly for at least 42 days.
7. A method for reducing dysmenorrhea by administering 20 μg of ethinylestradiol and 3 mg of drospirenone, daily and uninterruptedly for at least 42 days.
8. A method according to claim 6 wherein the uninterrupted administration is for more than one year.